Ensemble Capital: 7 Johnson & Johnson transactions (Ensemble Capital

7 Ensemble Capital Johnson & Johnson Trades

Ensemble Capital started to build up the position in Johnson & Johnson in Q1 2013. Since then they sold 8.28 Thousand shares. The investor completely sold their stake between Q2 2013 and Q3 2015.

Avg closing price

Price range

Sold -2.6 Thousand shares Q3 2015

Avg closing price $96.74

Price range $90.73 - $101.11

Sold 27.8% shares (-1 Thousand shares) Q2 2015

Avg closing price $100.14

Price range $97.46 - $103.96

Sold 21.7% shares (-1 Thousand shares) Q1 2015

Avg closing price $101.69

Price range $98.32 - $106.39

Sold 17.9% shares (-1 Thousand shares) Q2 2014

Avg closing price $101.07

Price range $96.54 - $105.76

Sold 26.1% shares (-1.98 Thousand shares) Q1 2014

Avg closing price $92.71

Price range $86.62 - $98.23

Sold 8.5% shares (-700 shares) Q2 2013

Avg closing price $84.86

Price range $81.11 - $88.59

New holding (+8.28 Thousand shares) Q1 2013

Avg closing price $75.74

Price range $70.74 - $81.53

News about Johnson & Johnson and Ensemble Capital

Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript

Johnson & Johnson (NYSE:JNJ ) Q3 2024 Earnings Conference Call October 15, 2024 8:30 AM ET Company Participants Jessica Moore - Vice President, Investor Rela...

seekingalpha.com, 7 months ago

Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender

No summary available.

Seeking Alpha, about 1 year ago

Capstan Therapeutics Raises $175M in Series B Financing

Capstan Therapeutics, a San Diego, CA-based biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted l...

FinSMEs, about 1 year ago